May 8, 1987
A controversial drug to treat two lethal types of cancer has won approval from the Food and Drug Administration for wider trials in humans, it was announced. An FDA spokeswoman said the agency will permit the National Cancer Institute to expand the use of interleukin-2 to a larger number of patients with advanced melanoma and kidney cancer. The treatment will be available to patients selected for participation in tests at NCI-approved cancer centers.
March 27, 1991 |
Frying, broiling and barbecuing produce potentially carcinogenic compounds in meat, chicken and fish, but microwaving, stewing and poaching do not, the National Cancer Institute said in reporting on a laboratory study. Researchers at the institute's Division of Cancer Etiology found that cooking at high temperatures and for a long time produced compounds that caused cancer in monkeys and other lab animals. Dr.
January 10, 2013 |
Between 1940 and 1971, many pregnant women were treated with a synthetic estrogen, diethylstilbestrol -- commonly known as DES -- to prevent miscarriage and other complications. The drug didn't work for that purpose, but it did have biological effects on the women who took it, as well as their children. On Wednesday, four sisters who'd been exposed to DES in the womb reached a settlement with one of the drug's principal makers, Eli Lilly & Co., during a federal trial in Boston, the Associated Press reported.
April 10, 2014 |
In their continuing quest to prove that coffee is indeed a health food, medical researchers analyzed the health records of nearly 180,000 Americans and determined that the ones with a daily java habit were less likely to get a common type of liver cancer than their less-caffeinated counterparts. The study , presented this week at the American Assn. for Cancer Research's annual meeting in San Diego, may not be enough to get your coffee break covered by your health insurance, but the results were striking.
November 8, 2011 |
Former undisputed heavyweight boxing champion Joe Frazier, who died Monday at the age of 67 after a brief bout with liver cancer, also had diabetes -- a major risk factor associated with the disease. Diabetes has been associated with the highest percentage (34%) of cases of the most common type of liver cancer, according to research by the National Cancer Institute. (The next highest was alcohol-related disorders, with 24%). Men and older adults are at higher risk of the cancer as well.
February 28, 1989 |
The federal government and the American Cancer Society on Monday announced a stop-smoking drive expected to reach more than one-fifth of the U.S. population and at least 15 million smokers. The National Cancer Institute estimates it will spend $116.5 million on the project, which is being billed as "the world's largest" effort to reduce smoking.
April 26, 1989
U.S. cancer researchers announced a joint cancer study with the Soviet Union. Scientists from the National Cancer Institute in Bethesda, Md., and the Dana-Farber Cancer Institute in Boston said the study--three separate clinical trials--will be the first of its kind. It will involve carefully monitored trials of new therapies on several hundred Soviet and American patients over two years, said Dr. Emil Frei III, director of the Dana-Farber institute, which is affiliated with Harvard Medical School.